Why ChromaDex Trounced the Market on Tuesday

1 min read

ChromaDex (NASDAQ: CDXC) was a hit on a slightly downbeat Tuesday for the broader market. Its shares raced nearly 10% higher on a price target increase from an analyst. 

New York-based investment bank H.C. Wainwright lifted its price target on the stock Tuesday. Actually, that’s an understatement; that level was shot into the sky, to $16 per share from the previous $7. The company maintains its buy recommendation on ChromaDex.

Image source: Getty Images.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

What’s Going On With Tech Stocks?

Next Story

Investing in These 3 Stocks Now Could Make You a Millionaire Retiree

Latest from Blog